Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End Point

Andrea DeCensi, Silvia Bruno, Massimo Costantini, +8

JNCI Journal of the National Cancer Institute

Phase Iia StudyPathologyOncologyGenitourinary CancerSurgical Pathology +16

Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.

Francesco Boccardo, Daniela Cannata, A. Rubagotti, +7

Journal of Clinical Oncology

Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.

Andrea DeCensi, Rosalba Torrisi, Silvia Bruno, +12

PubMed

Tumor BiologyIntermediate End PointUrologySurgical OncologySurrogate Biomarkers +13

Alternating chemo-radiotherapy in bladder cancer: A conservative approach

Marco Orsatti, Antonio Curotto, Luciano Canobbio, +9

International Journal of Radiation Oncology*Biology*Physics

Adaptive RadiotherapyUrologyRadiation TherapyMedicineOncology +1

Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study

Paolo Gontero, Marco Oderda, Vincenzo Altieri, +14

Urologia Internationalis

Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non–Muscle-Invasive Bladder Cancer

Matteo Puntoni, Marilena Petrera, Sara Campora, +7

Cancer Prevention Research

Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.

Francesca Mattioli, Antonio Curotto, Valeria Manfredi, +5

PubMed

Activity of 4-HPR in superficial bladder caner using DNA flow cytometry as an intermediate endpoint

Andrea DeCensi, Silvia Bruno, Walter Giaretti, +12

Journal of Cellular Biochemistry

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

Francesco Boccardo, Maurizio Pace, Domenico Guarneri, +3

Cancer

Recombinant α-2a Interferon Plus Vinblastine in the Treatment of Metastatic Renal Cell Carcinoma

Mario Roberto Sertoli, I. Brunetti, Andrea Ardizzoni, +8

American Journal of Clinical Oncology

Tumor BiologyUrologyPartial ResponseKidney ResearchMedicine +8